Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has provided an update.
Shanghai Heartcare Medical Technology Corp. Ltd. announced a change in its share incentive program by canceling previously granted share awards and issuing new ones. This move is aimed at motivating management personnel to maximize their efforts for the company’s success while also increasing efficiency and reducing administrative costs associated with the incentive schemes.
The most recent analyst rating on (HK:6609) stock is a Hold with a HK$47.00 price target. To see the full list of analyst forecasts on Shanghai Heartcare Medical Technology Corp. Ltd. Class H stock, see the HK:6609 Stock Forecast page.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai Heartcare Medical Technology Corp. Ltd. is a company based in China that operates in the medical technology industry. It focuses on developing and providing medical technology solutions, likely with a focus on cardiovascular health, given its name.
Average Trading Volume: 65,912
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.9B
See more insights into 6609 stock on TipRanks’ Stock Analysis page.